SMAD1/5 signaling in the early equine placenta regulates trophoblast differentiation and chorionic gonadotropin secretion. by Cabrera-Sharp, V et al.
SMAD1/5 Signaling in the Early Equine Placenta
Regulates Trophoblast Differentiation and Chorionic
Gonadotropin Secretion
Victoria Cabrera-Sharp, Jordan E. Read, Stephanie Richardson, Alycia A. Kowalski,
Douglas F. Antczak, Judith E. Cartwright, Abir Mukherjee, and Amanda M. de Mestre
Comparative Biomedical Sciences (V.C-S., J.E.R., S.R., A.A.K., A.M., A.M.d.M.), The Royal Veterinary
College, London NW1 0TU, United Kingdom; Baker Institute for Animal Health (D.F.A.), College of
Veterinary Medicine, Cornell University, Ithaca, New York 14853; and Biomedical Sciences (J.E.C.),
St George’s University of London SW17 0RE, London, United Kingdom
TGF superfamilyproteins, actingviaSMAD(Sma-andMad-relatedprotein)2/3pathways, regulate
placental function;however, the roleof SMAD1/5/8pathway in theplacenta isunknown.This study
investigated the functional role of bone morphogenetic protein (BMP)4 signaling through
SMAD1/5 in terminal differentiation of primary chorionic gonadotropin (CG)-secreting tropho-
blast. Primary equine trophoblast cells or placental tissues were isolated from day 27–34 equine
conceptuses. Detected by microarray, RT-PCR, and quantitative RT-PCR, equine chorionic girdle
trophoblast showed increased gene expression of receptors that bind BMP4. BMP4mRNA expres-
sion was 20- to 60-fold higher in placental tissues adjacent to the chorionic girdle compared with
chorionic girdle itself, suggesting BMP4 acts primarily in a paracrine manner on the chorionic
girdle. Stimulation of chorionic girdle-trophoblast cells with BMP4 resulted in a dose-dependent
and developmental stage-dependent increase in total number and proportion of terminally dif-
ferentiated binucleate cells. Furthermore, BMP4 treatment induced non-CG-secreting day 31 cho-
rionic girdle trophoblast cells to secrete CG, confirming a specific functional response to BMP4
stimulation. Inhibition of SMAD2/3 signaling combined with BMP4 treatment further enhanced
differentiation of trophoblast cells. Phospho-SMAD1/5, but not phospho-SMAD2, expression as
determined byWestern blotting was tightly regulated during chorionic girdle trophoblast differ-
entiation in vivo,with peak expressionof phospho-SMAD1/5 in vivonoted at day 31 corresponding
to maximal differentiation response of trophoblast in vitro. Collectively, these experiments dem-
onstrate the involvement of BMP4-dependent pathways in the regulation of equine trophoblast
differentiation in vivo and primary trophoblast differentiation in vitro via activation of SMAD1/5
pathway, a previously unreported mechanism of TGF signaling in the mammalian placenta.
(Endocrinology 155: 3054–3064, 2014)
Placental trophoblast cells perform nutritional, endo-crine, and immunomodulatory functions essential to
the survival of the developing fetus. Mammalian tropho-
blast differentiation is tightly regulated through the ex-
pression of transcription factors (intrinsic regulators),
growth factors (extrinsic regulators), and components of
their associated signaling pathways (1). Chorionic gonad-
otropin (CG) is secreted by both horse and human pla-
centa and is critical to maintenance of early pregnancy.
Production of CG is dependent on the differentiation of
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specialized CG-secreting cells, binucleate (horse) and syn-
cytiotrophoblast (human) (2, 3). These 2 cell types share
the expressionof the transcription factor glial cellsmissing
1 (GCM1), which is rapidly induced in vivo during dif-
ferentiation of both equine and human trophoblast (3, 4).
The extrinsic factors that regulate terminal differentiation
of primary equine binucleate trophoblast cells and CG
secretion remain elusive.
The chorionic girdle is a unique transient structure of
the equine placenta that gives rise to the endometrial cups.
Development of the equine chorionic girdle begins around
day 25 of gestation, at which time the uninucleate tropho-
blast cells undergo a period of rapid proliferation (2). Pre-
vious studies of cell morphology (5) and the kinetics of
equine (e) CG expression (3, 6), indicate that induction of
terminal differentiation of the binucleate trophoblast cells
begins around day 31 of pregnancy. The number of binu-
cleate cells then rapidly increases until around day 36–38
(7–10). Several growth factors including epidermal
growth factor, vascular endothelial growth factor, hepa-
tocyte growth factor-scatter factor, and TGF1 are ex-
pressed by the equine endometrium and avascular meso-
derm that abut the chorionic girdle (11–16; reviewed by
Reference 17), but the functional role of these growth fac-
tors indifferentiationof chorionic girdle trophoblast is not
known.
TGF- proteins are expressed at the fetal-maternal in-
terface during human pregnancy and are implicated in the
promotion of pre- and postimplantation embryonic de-
velopment (18). Bone morphogenetic protein (BMP)4 is a
member of the TGF- ligand superfamily, which is a large
family of dimeric proteins with multifunctional roles in-
cluding cellular proliferation, differentiation, migration,
and apoptosis (19). BMP4 functions through binding to
and phosphorylating a type I and II serine/threonine ki-
nase receptor, resulting in the activation of downstream
intracellular signals via phosphorylation of the receptor-
regulated SMAD (Sma- and Mad-related protein)1/5/8
transcription factors, which complex with SMAD4 to ini-
tiate transcription (19, 20). BMP4 signaling can be mod-
ified through a number of regulatory inputs, namely avail-
ability of the ligand (BMP4), restricted expression of
specific type I (BMP receptor, type IA [BMPR1A] and
BMP receptor, type IB [BMPR1B]), and type II (BMP re-
ceptor type II, BMPR2) receptors, and the presence of the
inhibitory pseudoreceptor, BMP and activin membrane-
bound inhibitor (BAMBI) (21). TGF signaling through
SMAD2/3 proteins has been described in a number of
studies in normal and preeclamptic placentas (22–29). In
contrast, little is known about the function of ligands that
signal through SMAD1/5/8 proteins, such as BMP4. Tro-
phoblast lineages have been generated from human em-
bryonic stem cells (ESCs) derived from human blastocysts
“primed” by BMP4 supplementation alone or in combi-
nation with other factors (30–39). However, the role of
BMP4-dependent SMAD1/5 signaling in differentiation
of primary trophoblast cells in vitro and in vivo is not
known.
There is restrictedavailabilityofhumanplacental tissue
during early pregnancy and controversy about the avail-
ability of in vitro systems that can adequately serve as a
model for early events in the human placenta (reviewed by
Reference 40), a period in development when embryonic
losses are high (41). Studies in the horse may also prove
informative to our understanding of the fundamental
mechanisms of human trophoblast differentiation (42).
CG is a hormone critical to the maintenance of pregnancy
that is secreted uniquely by the horse and humanplacenta.
Equine binucleate trophoblast cells and human syncy-
tiotrophoblast cells share expression of growth factors,
transcription factors, and components of their associated
signaling pathways (3, 4, 42). Further, we have previously
shown that it is possible to exploit the late implantation of
the equine placenta to isolate pure populations of tropho-
blast cells at multiple stages of binucleate trophoblast de-
velopment from the same stallion/mare combination (3).
These features of equine pregnancy provide us with a
unique resource to dissect molecular events that regulate
differentiation of CG-secreting trophoblast cells in vivo,
and so integrate molecular data with physiological
function.
In this study we investigated the role of BMP-signaling
pathways in equine chorionic girdle trophoblast differen-
tiation in vitro and in vivo. Specifically, we elucidate a role
for BMP4 in the regulation of terminal differentiation of
and subsequent CG secretion from trophoblast cells of the
chorionic girdle via activation of the SMAD1/5/8 path-
way. Furthermore, we show that when the SMAD 2/3
pathway is inhibited, BMP4-induced terminal differenti-
ation of CG-secreting trophoblast cells is further
increased.
Materials and Methods
Animals
Mares aged 3–7 years were maintained at the Royal Veteri-
naryCollege, and animal carewas performed in accordancewith
theAnimals (Scientific Procedures)Act1986guidelines set by the
HomeOffice andEthicsCommittee of theRoyalVeterinaryCol-
lege. The reproductive cycle was manipulated, and pregnancies
were established as previously described using semen from 3
stallions (3).
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Tissue collection
Conceptuses were recovered by nonsurgical uterine lavage
with established methods (3) between days 27 and 34 of preg-
nancy. Three or four conceptuses per development stage were
collected for each individual experiment. The sex of the concep-
tuseswas not determined. Conceptusesweremicrodissected into
chorionic girdle, allantochorion, chorion, yolk sac, bilaminar
omphalopleure, and fetus.Human first-trimesterplacental tissue
was obtained as previously described (43) (Wandsworth Local
Research Ethics Committee approval reference 01.96.8).
Culture and stimulation of trophoblast cells
To gain a pure population of trophoblast cells, strips of chori-
onic girdle were placed into DMEM, and the chorionic girdle tro-
phoblast cells were gently removed from basement membrane and
underlyingavascularmesodermalcell layerandculturedasperpub-
lished methods (8). Cells were supplemented with 1–100 ng/mL
human recombinant BMP4 (R&D Systems) or an equivalent vol-
ume of PBS/BSA. TheA83–01 inhibitor, selective for activin recep-
tor type-1B (ACVR1B), TGF receptor 1 (TGFBR1) and activin A
receptor type IC (ACVR1C) (Tocris), was used at a final concen-
tration of 1 M.Media were harvested after 72 hours, and super-
natant was aliquoted and stored at20°C.
Quantification of binucleate cell differentiation
and eCG secretion
Binucleate differentiation was quantified by measurement of
the number of nuclei per cell usingCellTrace BoDIPRTRmethyl
ester and nuclear stain Hoechst and subsequent fluorescent mi-
croscopy after 72 hours in culture. Using a fluorescent micro-
scope, 5 images perwellwere captured andanalyzedusing Image
J to ascertain the total number of binucleate cells within each
image. The concentration of eCG in medium recovered from
cultured chorionic girdle cells after 3 days in culture was deter-
minedusingapregnantmare serumgonadotropin enzyme linked
immunoassay (DRGInternational), aspreviouslydescribed (44).
RNA isolation and cDNA synthesis
Total RNA was isolated from snap-frozen equine conceptus
tissue, and human placental tissue was stored in RNAlater (In-
vitrogen), followinghomogenizationbyQIAshredder (Qiagen,),
using an RNeasy kit (Qiagen) as directed by the manufacturer.
RNA (500 ng)wasDNase I treated (Invitrogen), and first-strand
cDNAsynthesiswas performedusingMoloneymurine leukemia
virus reverse transcriptase (US Biochemical Corp) as per the
manufacturer’s guidelines.
RT-PCR, quantitative RT-PCR, and microarray
PCR was performed using standard methods. Amplification
of 15 ng of cDNAwas performed in a 20 L reaction using 10
PCR buffer, 0.2 mM each deoxynucleotide triphosphate, 1.5
mM MgCl (Invitrogen), 0.25 M each primer, and 1.25 L
recombinantTaqDNApolymerase (Invitrogen).Cyclingparam-
eters for PCRwere as follows for all amplified cDNAs: an initial
denaturation step of 2 minutes at 94°C, followed by 35 cycles of
30 seconds at 94°C, 30 seconds at 59°C, and 1 minute at 72°C,
and a final extension step of 10minutes at 72°C. Tenmicroliters
of each PCR were run on a 1% (wt/vol) agarose gel to visualize
PCR products. The PCR products were purified, cloned, and
sequenced to confirm the specificity of the PCR product. Primer
sequences are shown in Supplemental Table 2.
Real-time RT-PCRs for amplification of equine BMP4,
BMPR2, BMPRIA, BAMBI, RGM domain family member B
(DRAGON), or the housekeeper gene equine Succinate Dehy-
drogenase Complex, Subunit A, Flavoprotein (SDHA) mRNA
were performed using SYBR Green chemistry (KAPA SYBR
FAST Universal qPCR kit; KAPA Biosystems). PCR was carried
out using a C-1000 thermal cycler andCFX-96Real time system
(Bio-Rad Laboratories) in a total volume of 20 L. PCRs were
carried out for 38 cycles of 30 seconds at 95°C, 30 seconds at
60°C, and 20 seconds at 72°C. A melting curve was set to run
from 60°C to 95°C. A dissociation curvewas performed after each
experiment to confirm that a single product was amplified. For
BMP4 and SDHA, a standard curve was generated using known
copynumbersof purifiedPCRproducts for eachgene.Each sample
was normalized relative to BMP4 copy number in the chorionic
girdle (spatial assay). For BMPRIA, BMPR2, BAMBI, and
DRAGON, relative gene expression in days 27–34 chorionic girdle
was calculatedusing thePfafflmethod (45), taking into account the
efficiencyof the reaction for each individual gene. Primer sequences
are shown in Supplemental Table 3. Microarray data used in this
study have been previously reported (46).
Western blot analysis
Tissueswere groundand lysedon ice in lysis buffer containing
20 mM Tris-HCl (pH 8), 300 mM KCl, 1% NP-40 (vol/vol), 2.5
mM EDTA, 1 mM VO4, 10% glycerol, with a protease inhibitor
cocktail (Minicomplete protease inhibitor;Roche). Protein concen-
trations were determined using Bradford assay (Bio-Rad Labora-
tories). Protein frommouse spleen (positive control), chorionic gir-
dle, chorion, allantochorion, and yolk sack was diluted with lysis
buffer. A total of 40 g protein per well was loaded and separated
by SDS-PAGE on a 10% (wt/vol) polyacrylamide gel before being
transferred to a nitrocellulosemembrane using aMini-PROTEAN
Tetracellwet transferunit (Bio-RadLaboratories).Themembranes
were incubated overnight at 4°C in a 1:500 dilution of rabbit an-
tihuman Total SMAD5, phospho-SMAD (pSMAD)1/5, total
SMAD2 (Cell Signaling Technology), or pSMAD2 (Millipore
Corp) polyclonal antibodies each in Tris-buffered saline-Tween 20
containing5%(wt/vol)nonfatmilk.Sequencealignmentconfirmed
that the human peptide sequences against which the SMAD1/5 and
SMAD2 antibodies were directed shared 99%, 100%, and 100%
amino acid identities with the corresponding regions of equine
SMAD1, SMAD5, andSMAD2, respectively.Membraneswere incu-
batedwith a 1:10 000 dilution of goat antirabbit IgG secondary anti-
body conjugated to horseradish peroxidase (Sigma) in Tris-buffered
saline-Tween20containing5%(wt/vol)nonfatmilk. SMADproteins
were visualized by incubating with ECL plus detection reagents
(PerkinElmer)andexposedontoHyperfilmECL.Toconfirmintegrity
ofprotein transfer,andasa loadingcontrol,membraneswerestripped
and reprobed for-actin using amonoclonalmouse-actin antibody
(Sigma)atadilutionof1:5000.DensitometryanalysisofWesternblots
was carried out using ImageJ 1.47b software.
Statistics
All statistical tests were performed by using GraphPad Prism
4 statistical software, version 6 (GraphPad). Each experiment
was repeated 3–4 times with tissue from a different conceptus on
each occasion. Having confirmed the distribution of each data set,
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themean (ofmeans) and SEMwere calculated for each experimen-
tal condition across the 3–4biological replicates.Quantification of
BMP4 expression temporally and SMAD protein expression was
compared between the number of days gestation by using one-way
ANOVAwith repeated-measures and the post hoc Tukey’s multi-
ple-comparison test. Quantification of BMP4 expression spatially
was compared between tissues and was analyzed by one sample t
test. BMPRIA, BMPR2, BAMBI, DRAGON, and BMP4 expres-
sion in day 27–34 chorionic girdle was compared using Kruskal-
Wallis one-way ANOVA. The total number of binucleate tropho-
blastcellswascomparedbothbetweenthenumberofdaysgestation
using one-way ANOVA with repeated measures and the post hoc
Tukey multiple-comparison test, or by both time and treatment,
using repeated measures by 2 factors followed by Tukey or Sidak
multiple-comparison testwhere appropriate.P .05was accepted
as statistically significant in all tests.
Results
Receptors for TGF superfamily ligands are tightly
regulated in the chorionic girdle
Using data generated with a 44 000 equine gene probe
expression array (46), relative expression of 7 type I, 3 type
II,and5accessoryTGFsuperfamilyreceptors ingestational
day 34 chorionic girdle tissuewas compared to adjacent day
34 chorion tissue (Supplemental Table 1). We searched for
receptors that had increased expression in the chorionic gir-
dle (terminally differentiated trophoblasts that secrete CG)
compared with chorion (undifferentiated trophoblasts that
do not secrete CG).We report that the chorionic girdle pref-
erentially expresses those receptors that are known to bind
BMP2,BMP4,andBMP7(SupplementalTable1).Wefound
noevidenceofup-regulatedexpressionof eitherTGF1-spe-
cific type I receptor (TGFR1) or its type II receptor
(TGFBR2);neitherdidwe findevidence for the expressionof
its SMAD1/5/8-specific pathway type I receptor activin re-
ceptor type-II-like I (ACVRL1). TGF receptor III
(TGFBR3) and endoglin, both associated accessory recep-
tors to TGF1, were down-regulated in the chorionic girdle
(Supplemental Table 1).
Using RT-PCR, we confirmed expression of the type I
receptor BMPR1A and type II receptor BMPR2 in chori-
onic girdle tissue at days 27, 30, 31, and 34 prior to and
during the period of binucleate cell differentiation in vivo
(Figure 1A). BMPR1B was not detected in any of the cho-
rionic girdle tissues tested. These results suggest that in
these chorionic girdle trophoblast cells, BMP may signal
through the BMPR1A and BMPR2 dimer. The BMP4-
specific accessory receptors,Dragon andBAMBI, are also
expressed at days 27, 30, 31, and 34. As expected,GCM1
mRNA expression, a marker of chorionic girdle tropho-
blast cells (3), was confined to the chorionic girdle tissue
and was not observed in positive control tissues. Quanti-
tative real time RT-PCR analysis was additionally used to
compare temporal expression of these receptors in the
chorionic girdle. There was no significant difference in
expression levels of BMPR2, BAMBI, and Dragon in the
chorionic girdle (Figure 1B) between days 27 and 34 of
pregnancy. BMPRIA expression was modestly increased
in day 34 chorionic girdle (1.7-fold) when compared with
day 31 chorionic girdle (P  .05).
BMP4 stimulates terminal differentiation of
chorionic girdle trophoblast cells in vitro
Next, the number of binucleate trophoblast cellswithin
the pure population of chorionic girdle trophoblast cells
Figure 1. Temporal mRNA expression of type I, type II, and accessory
receptors specific for the ligand BMP4 in chorionic girdle tissue from
day 27, 30, 31, and 34 conceptuses. A, Qualitative RT-PCR analysis of
temporal receptor expression in the chorionic girdle. Amplicons were
generated using primers specific for equine BMPR1A, BMPR1B,
BMPR2, BAMBI, DRAGON, GCM1, and BACTIN (as control) mRNA, and
all bands observed in all tissues with each primer set are of the correct
predicted size: 306, 343, 364, 264, 269, 450, and 346 bp,
respectively. The figure shows typical RT-PCR product gels (n  3) in
which the tissue-specific mRNA expression profile was representative
of 3 independent chorionic girdles. NTC, no template control. Equine
testis and nonpregnant uterus were used as control tissues (lanes
marked VE). B, Real time quantitative RT-PCR expression of BMPR1A,
BMPR2, DRAGON, and BAMBI mRNA in days 27–34 chorionic girdle.
Data points represent the values for individual conceptuses (n  4,
except for day 27 [n  3] because one sample failed to meet control
gene validation parameters and was excluded from the dataset).
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derived from day 30/31 conceptus’ (depicted in Figure 2,
A and B) were quantified following culture in the absence
or presence of 1, 10, or 100 ng/mL BMP4 for 72 hours
(Figure 2C). We observed a significant increase (P .01)
in total binuceate cell number when the chorionic girdle
trophoblast cells were treated with 100 ng/mL recombi-
nant human BMP4 (Figure 2C). To confirm that recom-
binant human BMP4 treatment was biologically active on
the equine chorionic girdle trophoblast cells, we con-
ducted RT-PCR for DNA-binding protein inhibitor ID-1
Figure 2. Effects of BMP4 stimulation on terminal differentiation of chorionic girdle trophoblast. Pure populations of chorionic girdle cells from 4
different stages of chorionic girdle development were cultured in the presence or absence of 1–100 ng/mL BMP4, over 72 hours. The total number
of binucleated cells was quantified in 5 randomly selected fields for each treatment group; the depicted pooled data represent the mean (of
means)  SEM for 3 individual conceptuses at each development stage. Representative images of vehicle treated (A) and 100 ng/mL BMP4 treated
(B) chorionic girdle trophoblast cells in culture stained with CellTrace and Hoeschst. C, Quantification of binucleate trophoblast cells following
culture in absence or presence of 1, 10, or 100 ng/mL BMP4 for 72 hours. D, DNA-binding protein inhibitor ID-1 (ID1) mRNA expression in day 30
and day 31 trophoblast cells in the absence (V) or presence (BMP4) of 100 ng/mL BMP4. E, Quantification of binucleate cells following culture in
the presence (black bars) or absence (white bars) of 100 ng/mL BMP4 for 72 hours, derived from 3 different stages of chorionic girdle
development on day 34 of pregnancy (positive control). F, Equine CG secretion from chorionic girdle trophoblast cells treated in the absence or
presence of 100 ng/mL BMP4 and measured by equine CG ELISA. Data represents mean  SEM and were analyzed by repeated-measures ANOVA
followed by Tukey multiple-comparison test (**, P  .01) relative to corresponding vehicle cells, or by repeated measures by 2 factors followed by
Tukey or Sidak multiple comparison test (*, P  .05; **, P  .01; ***, P  .001 relative to corresponding vehicle cells. ˆˆ, P  .01 (D31 v D32/33);
ˆˆˆ, P  .001 (D30 v D31) relative to corresponding 100 ng/mL BMP4-treated cells.
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(ID1), a major transcriptional target of BMP signaling. In
comparison with vehicle-treated cells, BMP4 stimulation
resulted in increased expression of ID1 mRNA in chori-
onic girdle trophoblast cells in vitro (Figure 2D). Subse-
quently we quantified the total number of binucleate cells
following culture in the presence or absence of 100 ng/mL
BMP4 for72hours, at 3different stages of chorionic girdle
development: day 30, 31, and 32/33 of gestation. Termi-
nally differentiated cells derived from a day 34 conceptus
acted as a positive control (Figure 2, E and F). The re-
sponse to BMP4 treatment was dependent on the devel-
opment stage. BMP4 treatment significantly increased to-
tal binucleate cell number at day 30 (P .05), day 31 (P
.001), and day 32/33 (P  .01) when compared to corre-
sponding vehicle-treated cells (Figure 2E). Furthermore,
the rate of differentiation in day 31 chorionic girdle tro-
phoblast cells was significantly higher than in BMP4-
treated cells from day 30 (P  .001) and day 32/33 (P 
.01) chorionic girdle (Figure 2E). Compared with vehicle-
treated cells, 100 ng/mL BMP4 induced eCG secretion
from immature non-CG-secreting chorionic girdle cells at
day 31, but not day 30 (Figure 2F), confirming a specific
functional response to BMP4 stimulation. Moreover,
daily treatment of 100 ng/mL BMP4 for 3 days can sig-
nificantly further stimulate differentiation of day 30 cells
comparedwith vehicle-treated cells (P .05), comparable
to the differentiation rate seen in day 31 cells (Figure 3).
However, daily treatment of BMP4 does not serve to fur-
ther increase the total binucleate cell numbers in day 31
chorionic girdle trophoblast cells compared with a single
dose of 100 ng/mL BMP4 and visualized 72 hours later
(Figures 2E and 3).
Inhibition of SMAD2/3 pathway induces further
increases in terminal differentiation of chorionic
girdle trophoblast cells in vitro
We report that inhibition of the alternative SMAD2/3
signaling pathway with 1 M A83–01 (47) in combina-
tion with daily treatment of 100 ng/mL BMP4 for 3 days
results in a further increased rate of differentiation of cho-
rionic girdle trophoblast in vitro (Figure 3). In both day 30
and day 31 chorionic girdle trophoblast cells a minimum
of a 5-fold increase in cell differentiation was observed in
cells treated with both BMP4 and A83–01 when com-
pared with the corresponding vehicle-treated cells (P 
.001,P .001, for both day 30 and day 31). Furthermore,
a 2 fold-increase in the number of binucleate cells treated
with the combination treatment (BMP4 andA83–01)was
observed when compared to the corresponding BMP4
alone-treated cells (P  .001, P  .001, for both day 30
and day 31). There was no significant difference between
the response observed in day 30 and day 31 either with
BMP4 alone orwhen stimulatedwith BMP4 andA83–01.
The number of terminally differentiated cells in both
day 30 and day 31 chorionic girdle trophoblast cells was
significantly increased when the cells were treated with
A83–01 alone compared with vehicle (P .001) and rel-
ative to the corresponding BMP4-treated cells (day 30,
P  .001; and day 31, P  .05) (Figure 3). In addition,
there was no significant difference in the number of ter-
minally differentiated cells in A83–01 alone-stimulated
day 30 cells compared with the combination BMP4/
A83–01 treatment, whereas BMP4 had a significant ad-
ditive effect in the BMP4/A83–01 combination-treated
cells over A83–01 alone-treated day 31 cells (P  .001).
SMAD1/5 signaling is activated during chorionic
girdle development in vivo
Antibodies directed against human phospho-
SMAD1/5, human total SMAD1/5, human phospho-
SMAD2/3, and human total SMAD2/3were able to detect
a single equine protein of approximately 60 kDa in cho-
rionic girdle of different developmental stages. We subse-
quently report that there is a significant increase in phos-
pho-SMAD1/5 at day 30, from day 27, indicating that
SMAD1/5 signaling is activated during chorionic girdle
development in vivo and peaks at day 31, corresponding
with the initiation of binucleate cell differentiation (Figure
4, A and B). Furthermore, we observed very little total and
phospho-SMAD1/5 in the chorion, indicating that regu-
lationof the SMAD1/5pathway is specific to the chorionic
girdle (Figure 4A). There was no observed regulation of
Figure 3. Effect of daily treatment of BMP and SMAD2/3 pathway
inhibitor A83–01 on terminal differentiation of chorionic girdle
trophoblast cells from day 30 and day 31 conceptuses. Pure
populations of chorionic girdle cells were treated daily for 3 days in the
presence or absence of 100 ng/mL BMP4, 1 M A83–01 inhibitor, or
both. The total number of binucleated cells was quantified in 5
randomly selected fields for each treatment group; the depicted
pooled data represent the mean (of means)  SEM for 3 individual
conceptuses at either gestational day 30 or day 31. Data were
analyzed by repeated measures by 2 factors followed by Tukey
multiple-comparison test (*, P  .05; **, P  .01; ****, P  .0001
relative to corresponding vehicle cells. ˆ, P  .05; ˆˆˆ, P  .001; ˆˆˆˆ, P 
.0001 relative to corresponding 100 ng/mL BMP4-treated cells. ###,
P  .001 relative to corresponding 100 ng/mL BMP4 plus 1 M
inhibitor-treated cells.
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the pSMAD 2/3 proteins in either chorionic girdle or cho-
rion tissue (Figure 4, A and C).
BMP4 expression indicates the ligand may act on
the chorionic girdle primarily through paracrine
signaling in vivo
Having observed expression of the BMPR1A and
BMPR2 receptors in the chorionic girdle, a functional re-
sponse to BMP4 in vitro, and activation of SMAD1/5 sig-
naling in vivo, we then looked to determine which of the
placental membranes expressed the ligand BMP4. In day
30/31 conceptuses, BMP4 expression in the chorion and
yolk sac was 20- to 60-fold higher (P .05) than expres-
sion levels in the chorionic girdle, with a trend toward
higher expression in the allantochorion (P .065) (Figure
5A). We observed expression of BMP4mRNA at days 27
and 30 in the chorionic girdle with no expression detect-
ablebyRT-PCRatdays31and34 (Figure5B). Subsequent
quantitative RT-PCR analysis showed thatBMP4mRNA
expression was significantly decreased at day 34 (10.9-
fold) when compared with day 30 chorionic girdle (P 
.05) (Figure 5C).
Discussion
Implantation of the equine placenta occurs relatively late
in pregnancy and following differentiation of chorionic
girdle trophoblast cells that give rise to the CG-secreting
binucleate cells of the endometrial cups.Hereweexploited
these features of early equine pregnancy to study BMP4
signaling prior to, during, and after terminal differentia-
Figure 4. SMAD signaling protein expression in chorionic girdle and
chorion tissue isolated from day 27, 30, 31, and 34 conceptuses.
Western blots were probed with antibodies raised against human
peptide sequences in SMAD1/5 and pSMAD1/5, or SMAD2, pSMAD2
and murine -actin (as controls) (panel A). Mouse spleen was used as a
positive control tissue (). Each Western blot was quantified by
densitometry (panels B and C). Data were analyzed by repeated-
measures ANOVA followed by Tukey multiple-comparison test (*, P 
.05) relative to day 27 chorionic girdle (panels B and C). This
representative panel shows the pattern of immunoreactive proteins
recognized in equine chorionic girdle tissue protein preparations,
confirming that the antibodies directed against the human SMAD1/5
and pSMAD 1/5, SMAD2, and pSMAD2 recognized a single equine
protein of approximately 60 kDa. Each panel shows typical Western
blots in which the tissue-specific protein expression profile was
representative of 3 conceptuses.
Figure 5. Temporal and spatial expression of BMP4 mRNA in equine
conceptus tissue. A, Quantitative spatial expression of BMP4 mRNA in
chorionic girdle (CG) and adjacent day 30/31 conceptus tissues:
chorion (CHR), allantochorion (ALC), and yolk sac (YS). The data
represent the median for 3 individual conceptuses. Copy numbers
were normalized to 225 000 copies of the housekeeping gene SDHA,
and data were expressed as fold change over BMP4 copy number in
the chorionic girdle. Data were analyzed by one-way ANOVA with
repeated-measures and the post hoc Tukey multiple-comparison test
or by one sample t test (*, P  .05 (0.0136) relative to chorionic
girdle), allantochorion relative to chorionic girdle  P  .065. B,
Qualitative temporal expression of BMP4 mRNA in chorionic girdle
tissue from day 27, 30, 31, and 34 conceptuses. The data represent 3
individual conceptuses. Equine testis and nonpregnant uterus were
used as control tissues (lanes marked C). C, Quantitative temporal
relative expression of BMP4 mRNA in chorionic girdle between days 27
and 34. Data represent median values for 4 independent conceptuses
for each developmental stage (*, P  .05).
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tion of CG-secreting chorionic girdle trophoblast cells us-
ing both in vivo generated trophoblast tissues and ex vivo
pure trophoblast cell populations that had experienced
minimal manipulation. We found that chorionic girdle
cells expressed the receptors for BMP4 in vivo and func-
tionally differentiated in response to BMP4 in vitro. We
alsodemonstrated that SMAD1/5activity in chorionic gir-
dle in vivo directly correlates with terminal differentiation
of chorionic girdle trophoblast with peak SMAD1/5 ac-
tivity evident at the initiation of chorionic girdle differen-
tiation. A number of reports have demonstrated that
BMP4 can drive ESCs down a trophoblast lineage (35–39)
across a number of species but the question remains as to
whether a requirement for BMP4 is specific to differenti-
ation of ESCs or whether it is a physiologically relevant
factor regulating differentiation of committed primary
trophoblast in vivo. Here we provide the first evidence of
a role for BMP signaling in vitro in primary trophoblast
cells and activity of the BMP pathway in vivo at specific
periods in early placental development that directly cor-
relate with trophoblast differentiation.
A number of positive and negative regulators of TGF
signaling through SMAD2/3 have been shown to play a
role in regulating trophoblast function (22, 25) and/or are
dysregulated in preeclamptic placentas (27, 29). We ini-
tially mined a microarray dataset for expression of recep-
tors in the chorionic girdle that can bind the ligand
TGF1, a TGF ligand that is rapidly increased in the
endometrium around the time of chorionic girdle devel-
opment and implantation (2, 13). A comparison of TGF
receptor expression between chorionic girdle and the ad-
jacent chorion highlighted that the chorionic girdle pref-
erentially expressed the receptors BMPR1A and BMPR2,
with little evidence of regulation of receptors that bind
TGF1. BMPR1A and BMPR2 are genes that encode pro-
teins that form a heterodimeric complex that can bind the
ligands BMP2, BMP4, and BMP7 and signal through
SMAD1/5/8. These 2 receptors are also expressed in the
elongating bovine conceptus (day 17, preimplantation)
and the undifferentiated bovine trophoblast cell line, CT1
(48). We have also demonstrated expression of BMPR1A
and BMPR2 in first-trimester human chorionic villous tis-
sues (Supplemental Figure 1). The expression of BMPR1A
and BMPR2 in the early equine, human, and bovine pla-
centa led us to propose that TGF signaling through the
alternative pathway, SMAD1/5/8, may also have a con-
served and important function in early mammalian
placentas.
As far as we are aware, BMP4 expression has not been
studiedor reportedpreviously inplacental or endometrial/
decidual tissues. A closely related family member BMP2
has been described in human decidual cells (22). During
the period of initiation of differentiation (days 30–31),we
found BMP4 expression levels in the chorion, allantocho-
rion, and yolk sacwere between 20- to 60-fold higher than
in the chorionic girdle. This suggests that BMP4 is likely to
predominantly regulate terminal differentiation of tro-
phoblast in the chorionic girdle through paracrine mech-
anisms from these adjacent tissues. Following activation
of SMAD1/5 in the chorionic girdle at day30,weobserved
a decrease in BMP4mRNA in the chorionic girdle at days
31 and 34. TGF ligand signaling has been shown to also
lead to inhibition of expression of the ligand itself, possi-
bly explainingwhy intrinsic expression of the ligand is lost
immediately following the initiation of differentiation.
In these studies, we also provide evidence of BMP sig-
naling in the chorionic girdle in vivo. Phosphorylated
SMAD1/5 expression, indicative of BMP signaling, was
higher in the chorionic girdle comparedwith adjacent cho-
rion and peaked at days 30–31 in the chorionic girdle,
correlating with the initiation of trophoblast differentia-
tion in vivo (3, 6). This regulation of SMAD1/5 signaling
was specific and in contrast to stable activity of the alter-
native SMAD2pathway. Indeed, activity of the SMAD2/3
pathway was not specific to the chorionic girdle and was
more likely to have a housekeeper role during this phase of
trophoblast development in thehorse. For example, itmay
play a role in maintaining proliferation in these tissues
during what is a rapid period of placental growth. Phos-
pho-SMAD5 activation decreased again in the chorionic
girdle at day 34 of pregnancy, a stage when most of the
trophoblast cells have already terminally differentiated. It
is plausible that this decrease in SMAD1/5 signaling may
be regulated at the level of the receptor, and supporting
this possibility we also observed a decrease in the expres-
sion of BMPR2 at day 34 when compared with days
27–31.
Studiesof themechanisms that regulatehumanprimary
trophoblast differentiation are challenging, primarily due
to the limited availability of placental tissue during key
windows in early trophoblast differentiationand technical
difficulties in separating the trophoblast cells from the sur-
rounding decidual cells (49). Consequently, much atten-
tion has been given to developing suitable models of hu-
man trophoblast differentiation. One such model is the
study of differentiation of human (h) ESCs (49). Anumber
of early reports demonstrated that BMP4 can drive hESCs
down a trophoblast lineage (35–39), but this model was
brought intoquestionmore recentlybyBernandoet al (50)
who state that BMP4 drives hESCs to differentiate pri-
marily toward mesoderm rather than trophoblast. They
also found that the methylation state of the BMP-induced
cells did not reflect primary trophoblast. Since this con-
flicting report there has been great effort to further eluci-
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date the role of BMP4 in the hESC model. Amita et al
report BMP4 conversion of hESCs to a cell type that ex-
presses a full range of trophoblast markers, has invasive
properties and secretes hCG (47). In comparison with
hESC induced to differentiate toward trophoblast, equine
chorionic girdle trophoblast have lost Eomesodermin
(EOMES) expression (3), a transcription factor required
for trophoblast stem cell renewal (51). Thus the results
reported here reflect an observed effect of growth factors
on the differentiation of a pure population of fully “com-
mitted” trophoblast as they differentiate into subpopula-
tions of trophoblast cells such as those cells that terminally
differentiate to secrete CG.
We identified that 100 ng/mL BMP4 alone resulted,
after 72 hours, in a doubling of the number of terminally
differentiated day 30/31 chorionic girdle trophoblast cells
most likely by promoting terminal differentiation because
proliferationwasnot inducedwith treatment.Response to
this treatmentwas very tightly regulated and developmen-
tal stage dependent, with the greatest response to treat-
ment in day 31 cells. The differentiation of these cells was
deemed functionally active because we observed that
BMP4 induced day 31, but not day 30, cells to secrete eCG
compared with vehicle-treated immature nonsecreting
day 30/31 cells. Further, BMP4 did not enhance CG se-
cretion from terminally differentiated day 34 trophoblast
(Figure 2F, positive control). This supports a role for
BMP4 in driving phenotypic change in the trophoblast,
therefore leading to the attainment of an altered differen-
tiation state that induces CG expression as opposed to
being, specifically, a direct inducer of CG subunit gene
expression and/or secretion. In the horse at least, these
observations also highlight the very narrow period in de-
velopment when differentiation events may be initiated
and demonstrate the crucial importance of carefully as-
sessing tissue responses at a number of carefully selected
windows in early placental development.
Reflecting the mutually opposing interplay that has
been reported between SMAD2/3 and SMAD1/5/8 signal-
ing (52, 53), blocking of the SMAD2/3 pathway alone
with an inhibitor of the receptors ACVR1B/TGFBR1/
ACVR1C resulted in a similar level of differentiation to
BMP4 alone. Maximal effect on differentiation was
achieved though when BMP4 was combined with the in-
hibitor of SMAD2/3 signaling.The exactmechanisms that
mediate this inhibitory action of SMAD2/3 signaling on
BMP signaling in trophoblast is yet to be determined. In
mouse mesenchymal cells (C2C12 cell line) (52) and
mouse embryonic stem cells (54), TGF and Nodal, re-
spectively, can inhibit BMP signaling, activation of
SMAD1/5, and induction of BMP-responsive genes via
regulation of inhibitory SMAD7. In mouse alveolar epi-
thelial type II cells, TGF also has been shown to inhibit
BMP signaling but, in this case, acting through antago-
nism inphosphorylations of the SMADs (53). In the horse,
TGF1 is rapidly up-regulated in the endometrium be-
tween days 30 and 40 of pregnancy, corresponding to the
timewhen the rate of trophoblast differentiation is rapidly
decreasing. Future studies that investigate thepossible role
of TGF and Nodal in inhibition of chorionic girdle dif-
ferentiation are warranted (13).
In conclusion, our findings support a role for BMP4
signaling in the regulation of terminal differentiation of
primary equine trophoblast cells via activation of the
SMAD1/5 pathway (Figure 6). The observation of BMP4
signaling in primary trophoblast provides a previously un-
reported mechanism of TGF signaling in the placenta
that is likely to be conserved across other mammalian
species.
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